Jobs / United States / Glaxosmithkline LLC
ViiV Healthcare (GSK) Head of Data and Technology Strategy
Glaxosmithkline LLC · 🇺🇸 USA - North Carolina - Durham
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles3 certified filings for “AIR & Vaccine Medical Insight Analyst” (Data Scientists) in NC: $107k–$127k, median $127k. Most were filed at wage level IV (67%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV is highly mission-driven in our unrelenting commitment to being a trusted partner for all people living with and affected by HIV. Our aim is to think, act, and connect differently through a focus on education on and treatment for HIV. We go to extraordinary lengths to deliver the sorts of breakthroughs, both in treatments, care solutions and communities, that really count. We go beyond the boundaries of medicine by taking a holistic approach to HIV through developing and supporting sustainable community programs and improving access to care. We are fully committed to push through every challenge until HIV/AIDS is eradicated. ViiV has played a significant part in delivering breakthroughs that have turned HIV into a manageable health condition. We offer the largest portfolio of HIV medicines available anywhere, and we continue our work to cater for the widest possible range of needs in response to the HIV epidemic. We are aware of how much is at stake for those affected by HIV and we show up every day 100% committed to the patients. Our work culture is fast-paced, diverse, inclusive, competitive, and caring. But ViiV isn’t just somewhere to work – it’s a place to belong, an invitation to bring your very best, and a team full of impact-driven team members who are hungry to make a difference. While we have been improving lives of HIV patients for 30 years, this is an especially exciting time to be at ViiV, as we evaluate novel approaches to treatment and prevention that could further reduce the impact of HIV on individuals and communities. The Head of Data & Technology Strategy is a senior strategic leadership role accountable for defining how data, technology, AI and automation will accelerate ViiV R&D priorities across Discovery, Development, Regulatory, CMC and portfolio decision-making. The role will translate scientific ambition into a prioritised portfolio with clear value drivers, investment requirements and measurable outcomes, and will decide the delivery pathway for each priority Working in close partnership with the Head of Strategy & Operations, Head of R&D, the R&D Leadership Team, R&D Operations, ViiV Digital & Technology, GSK R&D Technology, Quantitative Sciences and cross-functional partners, this leader will provide strategic judgement, technology fluency and disciplined execution. They will establish and operate clear interfaces between R&D as business owner and sponsor, and technology organisations as strategic partners accountable for requirements translation, architecture, platforms, delivery, technology controls and risk governance. The role will strengthen ViiV influence in enterprise R&D decisions, work with ViiV Digital & Technology to identify where existing GSK capabilities can be leveraged and trade-offs between internal and external solutions, and decide, where ViiV-specific or external solutions are needed to meet critical scientific and portfolio milestones. The leader will also drive adoption, digital fluency and benefits realisation so that technology investments translate into sustained business outcomes. The successful candidate will be able to operate through ambiguity, connect scientific and technical perspectives, simplify complex choices and build alignment across senior stakeholders while maintaining clear ownership, pace, governance and accountability. Data & Technology Strategy enables ViiV R&D to translate scientific and portfolio priorities into a focused data, technology and AI agenda. The function connects R&D business needs with technology capabilities, investment choices, governance and adoption to imp